Literature DB >> 11719638

Elevated cortisol levels in Cushing's disease are associated with cognitive decrements.

M N Starkman1, B Giordani, S Berent, M A Schork, D E Schteingart.   

Abstract

OBJECTIVE: The objective of this study was to use Cushing's disease as a unique human model to elucidate the cognitive deficits resulting from exposure to chronic stress-level elevations of endogenous cortisol.
METHODS: Forty-eight patients with a first episode of acute, untreated Cushing's disease and 38 healthy control subjects were studied.
RESULTS: Scores for four of five verbal IQ subtests were significantly lower in patients with Cushing's disease; their scores were significantly lower for only one nonverbal performance IQ subtest (block design). Verbal, but not visual, learning and delayed recall at 30 minutes were significantly decreased among patients with Cushing's disease. Although verbal delayed recall was significantly lower in these patients, the retention index (percentage), which compares the amount of initially learned material to that recalled after the delay, was not significantly decreased. There was no significant association between depression scores and cognitive performance. A higher degree of cortisol elevation was associated with poorer performance on several subtests of learning, delayed recall, and visual-spatial ability.
CONCLUSIONS: Chronically elevated levels of glucocorticoids have deleterious effects on particular domains of cognition. Verbal learning and other verbal functions seem more vulnerable than nonverbal functions. The results suggest that both the neocortex and hippocampus are affected.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11719638     DOI: 10.1097/00006842-200111000-00018

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  49 in total

1.  Stress-induced suppression of hippocampal neurogenesis in adult male rats is altered by prenatal ethanol exposure.

Authors:  J H Sliwowska; J M Barker; C K Barha; N Lan; J Weinberg; L A M Galea
Journal:  Stress       Date:  2010-07       Impact factor: 3.493

2.  Cognitive effects of tumour and surgical treatment in glioma patients.

Authors:  Andrea Talacchi; Barbara Santini; Silvia Savazzi; Massimo Gerosa
Journal:  J Neurooncol       Date:  2010-09-28       Impact factor: 4.130

3.  Hippocampal atrophy in systemic lupus erythematosus.

Authors:  S Appenzeller; A D Carnevalle; L M Li; L T L Costallat; F Cendes
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

Review 4.  Effects of cocaine on the hypothalamic-pituitary-adrenal axis.

Authors:  L Manetti; F Cavagnini; E Martino; A Ambrogio
Journal:  J Endocrinol Invest       Date:  2014-05-23       Impact factor: 4.256

5.  Understanding fibromyalgia and its related disorders.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

6.  Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls.

Authors:  Andrew Pearson; Annick de Vries; Scott D Middleton; Fiona Gillies; Timothy O White; Ian R Armstrong; Ruth Andrew; Jonathan R Seckl; Alasdair Mj MacLullich
Journal:  BMC Res Notes       Date:  2010-02-08

7.  Dual-release hydrocortisone and its benefits on cognitive function and quality of sleep.

Authors:  Clarissa Krekeler; Peter Kropp; Antje Katrin Blacha; Amir-Hossein Rahvar; Birgit Harbeck
Journal:  Endocrine       Date:  2021-02-24       Impact factor: 3.633

8.  11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics.

Authors:  Thekkepat C Sandeep; Joyce L W Yau; Alasdair M J MacLullich; June Noble; Ian J Deary; Brian R Walker; Jonathan R Seckl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

9.  A direct comparison of quality of life in obese and Cushing's syndrome patients.

Authors:  Smita Baid Abraham; Brent S Abel; Domenica Rubino; Tonja Nansel; Sheila Ramsey; Lynnette K Nieman
Journal:  Eur J Endocrinol       Date:  2013-04-15       Impact factor: 6.664

10.  Schizandrin prevents dexamethasone-induced cognitive deficits.

Authors:  Xiao Xu; Xing Zhou; Xiao-Wen Zhou; Zheng Zhang; Min-Jing Liao; Qi Gao; Huan-Min Luo
Journal:  Neurosci Bull       Date:  2012-07-18       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.